UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): December 31, 2013
Bacterin International Holdings, Inc.
|
(Exact Name of Registrant as Specified in Its Charter)
| ||
| Delaware | ||
|
(State or Other Jurisdiction of Incorporation)
| ||
| 001-34951 | 20-5313323 | |
| (Commission File Number) |
(IRS Employer Identification No.)
| |
|
600 Cruiser Lane Belgrade, Montana |
59714 | |
| (Address of Principal Executive Offices) |
(Zip Code)
| |
| (406) 388-0480 | ||
|
(Registrant’s Telephone Number, Including Area Code)
| ||
|
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | ||
Item 7.01 Regulation FD Disclosure.
The Company has issued a press release entitled “Bacterin Announces 2014 Donate Life Rose Parade Float Living Donor Honoree” which is attached as Exhibit 99.1 and incorporated herein.
The information in this Item 7.01 and the document attached as Exhibit 99.1 are being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended (the “Exchange Act”), nor otherwise subject to the liabilities of that section, nor incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
| Exhibit No | Description | |
|
99.1
|
Press Release of Bacterin International Holdings, Inc. dated December 31, 2013 entitled “Bacterin Announces 2014 Donate Life Rose Parade Float Living Donor Honoree” |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Dated: December 31, 2013 | BACTERIN INTERNATIONAL HOLDINGS, INC. | |
| By: | /s/ Daniel Goldberger | |
| Name: | Daniel Goldberger | |
| Title: | CEO | |
EXHIBIT INDEX
| 99.1 | Press Release of Bacterin International Holdings, Inc. dated December 31, 2013 entitled “Bacterin Announces 2014 Donate Life Rose Parade Float Living Donor Honoree” |
Bacterin Announces 2014 Donate Life Rose Parade Float Living Donor Honoree
BELGRADE, Mont.--(BUSINESS WIRE)--Dec.31, 2013-- Bacterin International Holdings, Inc. (NYSE MKT: BONE) is pleased to announce Kevin Noyes as its 2014 Donate Life Rose Parade Float® Living Donor Honoree. Kevin will be one of twelve, inaugural living-donor walkers who will be escorting the “Light up the World” themed float during the 5-mile parade route. The theme of this year’s Donate Life Rose Parade Float is designed to remember and honor deceased and living donors, as well as organ, eye, and tissue recipients. Bacterin is sharing this honor with American Donor Services.
Kevin has built a career focused on the gift of donation as an employee of American Donor Services. In June of 2012, he was able to extend his commitment even further by electing to be a living donor, and donating a kidney to a close friend’s father.
“We are delighted to honor Kevin Noyes and the selfless decision he made to save a life by becoming a Living Donor,” said Dan Goldberger, Bacterin’s President and CEO. “We have been able to see how the gift of donation can save and improve the lives of others, and we couldn’t be more grateful to be able to acknowledge Kevin and his family for their generous gift of life.”
2014 marks the first year that the Donate Life Rose Parade Float will honor Living Donors as walkers, in addition to the floragraphs that adorn the float remembering deceased donors, and the numerous float riders who are recipients of life saving organs, eyes, and tissues. Bacterin also sponsors messages of love and hope from donor families that adorn numerous flowers featured in the rose garden. To read some of these messages of remembrance, please visit Bacterin’s website. To learn more about Kevin Noyes, and other donors and recipients selected as honorees in the 2014 Donate Life Rose Parade Float, please visit www.donatelifefloat.org.
About the Pasadena Tournament of Roses®
The Pasadena Tournament of Roses is a volunteer organization that annually hosts the Rose Parade® presented by Honda, the Rose Bowl Game® presented by VIZIO and a variety of associated events. The Tournament's 935 volunteer members act as ambassadors of the organization within the community and serve on one of 31 committees that ensure the success of the parade and game. Collectively, they contribute upwards of 80,000 hours of manpower each year. The 125th Rose Parade presented by Honda, themed "Dreams Come True," will take place Wednesday, Jan. 1, 2014, followed by the 100th Rose Bowl Game presented by VIZIO. On Jan. 6, 2014, the Tournament also will host the 2014 VIZIO BCS National Championship at the Rose Bowl Stadium. For additional information on the Tournament of Roses please visit the official website at www.tournamentofroses.com.
About Bacterin International Holdings
Bacterin International Holdings, Inc. (NYSE MKT: BONE) develops, manufactures and markets biologics products to domestic and international markets. These products are used in a variety of applications including enhancing fusion in spine surgery, relief of back pain, promotion of bone growth in foot and ankle surgery, promotion of cranial healing following neurosurgery and subchondral repair in knee and other joint surgeries.
Bacterin's Medical Device division develops, employs, and licenses coatings for various medical device applications. For further information, please visit www.bacterin.com.
Important Cautions Regarding Forward-looking Statements
This news release contains certain disclosures that may be deemed forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to significant risks and uncertainties. Forward-looking statements include statements that are predictive in nature, that depend upon or refer to future events or conditions, or that include words such as "continue," "efforts," "expects," "anticipates," "intends," "plans," "believes," "estimates," "projects," "forecasts," "strategy," "will," "goal," "target," "prospects," "potential," "optimistic," "confident," "likely," "probable" or similar expressions or the negative thereof. Statements of historical fact also may be deemed to be forward-looking statements. We caution that these statements by their nature involve risks and uncertainties, and actual results may differ materially depending on a variety of important factors, including, among others: the Company's ability to meet its existing and anticipated contractual obligations, including financial covenant and other obligations contained in the Company’s secured lending facility; the Company’s ability to manage cash flow and achieve profitability; the Company's ability to develop, market, sell and distribute desirable applications, products and services and to protect its intellectual property; the ability of the Company's sales force to achieve expected results; the ability of the Company's customers to pay and the timeliness of such payments; the Company's ability to obtain financing as and when needed; changes in consumer demands and preferences; the Company's ability to attract and retain management and employees with appropriate skills and expertise; the Company’s ability to successfully conclude government investigations; the impact of changes in market, legal and regulatory conditions and in the applicable business environment, including actions of competitors; and other factors. Additional risk factors are listed in the Company's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q under the heading "Risk Factors." The Company undertakes no obligation to release publicly any revisions to any forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events, except as required by law.